Cargando…

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Kremer, Veronika, Ligtenberg, Maarten A., Zendehdel, Rosa, Seitz, Christina, Duivenvoorden, Annet, Wennerberg, Erik, Colón, Eugenia, Scherman-Plogell, Ann-Helén, Lundqvist, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674812/ https://www.ncbi.nlm.nih.gov/pubmed/29110706 http://dx.doi.org/10.1186/s40425-017-0292-8

Ejemplares similares

Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
por: Kremer, Veronika, et al.
Publicado: (2017)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
por: Tong, Le, et al.
Publicado: (2023)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

Migration of NK cells
por: Gismondi, Angela, et al.
Publicado: (2006)

Phenotypic and Functional Plasticity of CXCR6(+) Peripheral Blood NK Cells
por: Angelo, Laura S., et al.
Publicado: (2022)

NK-B cell cross talk induces CXCR5 expression on natural killer cells
por: Rascle, Philippe, et al.
Publicado: (2021)

Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
por: Jamali, Arezoo, et al.
Publicado: (2020)

Lymph node CXCR5(+) NK cells associate with control of chronic SHIV infection
por: Rahman, Sheikh Abdul, et al.
Publicado: (2022)

mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD
por: Li, Qiaojia, et al.
Publicado: (2021)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)

Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer
por: Bi, Huijuan, et al.
Publicado: (2019)

In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2017)

Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses
por: Paust, Silke, et al.
Publicado: (2010)

Implications of the accumulation of CXCR5(+) NK cells in lymph nodes of HIV-1 infected patients
por: Guo, An-Liang, et al.
Publicado: (2021)

NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1
por: Vo, Dang-Nghiem, et al.
Publicado: (2022)

CXCR7 functions in colon cancer cell survival and migration
por: WANG, HONGXIAN, et al.
Publicado: (2015)

Corrigendum to “In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging”
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2020)

CXCR6(+) NK Cells in Human Fetal Liver and Spleen Possess Unique Phenotypic and Functional Capabilities
por: Angelo, Laura S., et al.
Publicado: (2019)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021)

Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration
por: Chen, Dong, et al.
Publicado: (2015)

GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells
por: Inaguma, Shingo, et al.
Publicado: (2015)

The Role of SDF-1α-CXCR4/CXCR7 in Migration of Human Periodontal Ligament Stem Cells
por: Xu, Jialei, et al.
Publicado: (2023)

Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
por: Parodi, Monica, et al.
Publicado: (2018)

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
por: Romanski, Annette, et al.
Publicado: (2016)

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022)

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases
por: Grote, Stefan, et al.
Publicado: (2021)

Decidual CXCR4(+)CD56(bright)NK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failure
por: Tao, Yu, et al.
Publicado: (2021)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

NK cells and solid tumors: therapeutic potential and persisting obstacles
por: Tong, Le, et al.
Publicado: (2022)

STATs in NK-Cells: The Good, the Bad, and the Ugly
por: Gotthardt, Dagmar, et al.
Publicado: (2017)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells
por: Ellegård, Rada, et al.
Publicado: (2018)

Author Correction: Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration
por: Chen, Dong, et al.
Publicado: (2022)

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)

Osteoporosis and ageing affects the migration of stem cells and this is ameliorated by transfection with CXCR4
por: Sanghani-Kerai, A., et al.
Publicado: (2017)

CXCR4 Mediates Enhanced Cell Migration in CALM-AF10 Leukemia
por: Fertal, Shelby A., et al.
Publicado: (2022)

Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation
por: Xing, Baichun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0g4rps1rudv8ue15oj30sl5u4m